Clinical Trial Update: A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER [Phase 1]

View source ↗

Summary

This entry announces a Phase I clinical trial of ALPS12 for extensive stage small cell lung cancer, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• ALPS12

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 1 | Status: RECRUITING